12/08/2008
TVM Capital Life Science Practice Promotes Dr. Christoph Schröder and Ms. Hui Hsing Ma to General Partner
December 8, 2008, Munich, Germany – TVM Capital is pleased to announce the promotions of Dr. Christoph Schröder (Munich) and Ms. Hui Hsing Ma (Singapore/Munich) to General Partner. Both have worked with TVM Capital since 2004, and were previously Venture Partners for the TVM Capital Life Science Practice.
“Both Christoph and Hui Hsing have become in integral part of our investing team,” said Dr. Helmut Schühsler, managing partner of TVM Capital. “While Dr. Schröder focuses on growth capital investments of family-owned life science businesses in the German speaking countries, Ms. Ma represents TVM Capital in the Asian markets. They both have key skills that enhance our footprint in our target countries, contribute to the strong support we provide to our portfolio companies, especially when it comes to operational improvement and internationalization of the business, and allow TVM Capital to execute on our innovation and growth capital focused investment strategy.”
Christoph Schröder has extensive life science executive experience stemming from his tenure at BASF Pharma, where he was a member of the Executive Board based in London and President of two corporate functions: Global Production/Supply Chain and Corporate Marketing. Prior to this Dr. Schröder was Head of Strategy/M&A and Managing Director for BASF Pharma operations in the UK and Ireland.
Subsequently, he joined JSB Partners, a life science specialized transatlantic investment banking firm, as a partner. In this capacity he successfully executed several private placements, M&A and licensing transactions on behalf of biotech clients, including Probiodrug/OSI, Cardion/Roche and Tibotec-Virco/Johnson & Johnson.
He currently represents TVM Capital on the boards of Biotie Therapies, Probiodrug AG and Riemser AG.
Hui Hsing Ma previously co-led Global Biotechnology Investments in Vertex Management and made investments in several US and European biotech companies and VC funds. She had also been an advisor to international life science businesses on Asian expansion strategies and fundraising. In addition, she has more than 16 years experience in international investment, corporate finance and general management with leading global companies including Singapore Technologies, Banque Nationale de Paris, General Electric (USA) and Morgan Grenfell.
Press Contact
Monika Schlesinger
TVM Capital GmbH
Maximilianstr. 35, Eingang C
D- 80539 Munich, Germany
++49 (89) 998 992-0
Nancy Saucier
TVM Capital
101 Arch Street, Suite 1950
Boston, MA 02110, USA
+1 (617) 345 9320
